Stocks · Korea
002800
KOSDAQ
Sinsin Pharmaceutical
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
PER7.55x
PBR0.94x
EPS613 KRW
BPS4,933 KRW
ROE14.50%
Dividend yield1.73%
DPS80 KRW
Payout ratio13.05%
Returns and 52-week range
1W+3.94%
1M+1.32%
3M+5.60%
6M-17.06%
1Y-19.23%
YTD-21.69%
52W high6,990원
52W low3,900원
From 52W high-33.91%
Financial results (consolidated)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2022 | 919억 | 54억 | 44억 | 5.9% |
| 2023 | 1,026억 | 60억 | 46억 | 5.8% |
| 2024 | 1,064억 | 69억 | 48억 | 6.5% |
| 2025 | 1,138억 | 108억 | 93억 | 9.5% |
| Quarterly | ||||
| 2024 4Q | 253억 | 12억 | 7억 | 4.6% |
| 2025 1Q | 253억 | 13억 | 10억 | 5.0% |
| 2025 2Q | 296억 | 22억 | 14억 | 7.5% |
| 2025 3Q | 301억 | 40억 | 34억 | 13.2% |
| 2025 4Q | 288억 | 33억 | 35억 | 11.6% |
| 2026 1Q | 302억 | 32억 | 29억 | 10.5% |
Company
Address: 세종특별자치시 소정면 소정산단동로 9 -
Peers in the same sector
Recent filings
- 2026-08-14반기보고서 (2026.06)
- 2026-05-15분기보고서 (2026.03)
Source: DART (Financial Supervisory Service electronic disclosure)
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.